Bruce Neal

Also affiliated with The George Institute for Global Health, Imperial College London

NursingMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

9.9Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

New England Journal of Medicine(2017)10.1056/nejmoa1611925

Top 1%

9.9DataRank

Top 1%7805 citations

Vlado Perkovic, Kenneth W. Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu +5 more

Papers

Driven by 25 papers — median percentile 99. Top paper: “Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019”.

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

Journal of the American College of Cardiology(2020)10.1016/j.jacc.2020.11.010

N/A

14.2DataRank · unranked

11099 citations

George A. Mensah, Catherine O. Johnson, Giovanni Addolorato, Enrico Ammirati, Larry M. Baddour +65 more

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

New England Journal of Medicine(2017)10.1056/nejmoa1611925

Top 1%

9.9DataRank

Top 1%7805 citations

Vlado Perkovic, Kenneth W. Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu +5 more

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Stroke(2021)10.1161/strokeaha.120.031623

N/A

3.6DataRank · unranked

120 citations

Meg Jardine, Qiang Li, Brendon L. Neuen, Christopher P. Cannon, Dick de Zeeuw +95 more

Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria

Clinical Journal of the American Society of Nephrology(2021)10.2215/cjn.15260920

N/A

3.4DataRank · unranked

54 citations

Zien Zhou, Hiddo J.L. Heerspink, Carinna Hockham, Qiang Li, Rajiv Agarwal +18 more

Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease

Clinical Journal of the American Society of Nephrology(2021)10.2215/cjn.08780621

N/A

1.4DataRank · unranked

48 citations

Taha Sen, Clare Arnott, Bruce Neal, Jos G. W. Kosterink, Kenneth W. Mahaffey +9 more

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

The Lancet(2012)10.1016/s0140-6736(12)61766-8

N/A

1.4DataRank · unranked

11963 citations

Theo Vos, Abraham D Flaxman, Goodarz Danaei, Abbas Sheikhtaheri, Heather Adair-Rohani +254 more

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

The Lancet(2016)10.1016/s0140-6736(16)31679-8

N/A

1.3DataRank · unranked

7768 citations

Ashkan Afshin, Lily T Alexander, Zulfiqar A. Bhutta, Stan Biryukov, Michael Brauer +928 more

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

New England Journal of Medicine(2008)10.1056/nejmoa0802987

N/A

1.3DataRank · unranked

7380 citations

Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward +20 more

Cardiovascular and Renal Outcomes with Canagliflozin According to Baseline Diuretic Use: A Post Hoc Analysis from the CANVAS Program

ESC Heart Failure(2021)10.1002/ehf2.13236

N/A

0.967DataRank · unranked

23 citations

Clare Arnott, Brendon L. Neuen, Hiddo L. Heersprink, Kenneth W. Mahaffey, Christopher P. Cannon +11 more

Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials

Journal of the American Heart Association(2023)10.1161/jaha.122.028516

N/A

0.459DataRank · unranked

7 citations

Clare Arnott, Patrick Rockenschaub, Aletta E. Schutte, Lewis Carpenter, Muthiah Vaduganathan +13 more

Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE

International Journal of Cardiology(2022)10.1016/j.ijcard.2022.04.044

N/A

0.452DataRank · unranked

9 citations

Dan Wang, John W. McEvoy, Stephen Harrap, Katie Harris, Giuseppe Mancia +9 more

Association Between Circulating GDF‐15 and Cardio‐Renal Outcomes and Effect of Canagliflozin: Results From the CANVAS Trial

Journal of the American Heart Association(2021)10.1161/jaha.121.021661

N/A

0DataRank · unranked

32 citations

Jingwei Li, Brendon L. Neuen, Clare Arnott, Bruce Neal, Vlado Perkovic +6 more

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice

Kidney International(2020)10.1016/j.kint.2020.10.042

N/A

0DataRank · unranked

160 citations

Meg Jardine, Rajiv Agarwal, George L. Bakris, Christopher P. Cannon, David M. Charytan +15 more

Association of Baseline Diuretic Use With Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction: A Secondary Analysis From TOPCAT

Journal of Cardiac Failure(2021)10.1016/j.cardfail.2021.02.010

N/A

0DataRank · unranked

2 citations

Mark D. Huffman, Katherine Harrington, Abigail S. Baldridge, Jie Yu, Bruce Neal +3 more

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

The Lancet Diabetes & Endocrinology(2022)10.1016/s2213-8587(22)00172-3

N/A

0DataRank · unranked

104 citations

Zeinab Bidel, Dexter Canoy, Emma Copland, Derrick Bennett, Abbas Dehghan +95 more

Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS

Diabetes Care(2022)10.2337/dc22-0866

N/A

0DataRank · unranked

58 citations

Meir Schechter, Taha Sen, Priya Vart, Brendon L. Neuen, Bruce Neal +7 more

A Post Hoc Analysis of KidneyIntelX and Cardiorenal Outcomes in Diabetic Kidney Disease

Kidney360(2022)10.34067/kid.0002172022

N/A

0DataRank · unranked

4 citations

Dipti Takale, Bruce Neal, Kenneth W. Mahaffey, Yshai Yavin, Michael K. Hansen +4 more

Developing long-term strategies to reduce excess salt consumption in Nigeria

European Heart Journal(2022)10.1093/eurheartj/ehac025

N/A

0DataRank · unranked

10 citations

Nigeria Sodium Study Team, Mark D. Huffman, Adedayo E. Ojo, Vanessa Alfa, Clementina Ebere Okoro +23 more

Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

Circulation(2023)10.1161/circulationaha.123.067584

N/A

0DataRank · unranked

312 citations

Hiddo J.L. Heerspink, Priya Vart, Brian Claggett, Robert A. Fletcher, Clare Arnott +11 more

A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

Nature Medicine(2023)10.1038/s41591-023-02418-0

N/A

0DataRank · unranked

160 citations

Willem Collier, Tom Greene, Shiyuan Miao, Juhi Chaudhari, Gerald B. Appel +79 more

Criterion validation of nutrient profiling systems: a systematic review and meta-analysis

American Journal of Clinical Nutrition(2023)10.1016/j.ajcnut.2023.10.013

N/A

0DataRank · unranked

33 citations

Habiba Afrin, Mike Rayner, Simone Pettigrew, Allison Gaines, Damian Maganja +8 more

Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

Circulation(2024)10.1161/circulationaha.124.069568

N/A

0DataRank · unranked

168 citations

Yu Mi Kang, KyungAh Im, Brendon L. Neuen, Stefan D. Anker, Deepak L. Bhatt +24 more

Healthy Food Prescription Programs and their Impact on Dietary Behavior and Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis

Advances in Nutrition(2021)10.1093/advances/nmab039

N/A

0DataRank · unranked

153 citations

Daisy H. Coyle, Kathy Trieu, Bruce Neal, Dariush Mozaffarian, Matti Marklund +2 more

Potassium-enriched salt substitutes: supporting global cardiovascular and kidney health

The Lancet Global Health(2025)10.1016/s2214-109x(25)00235-9

N/A

0DataRank · unranked

2 citations

Martin H. de Borst, Tammy M. Brady, Mogamat‐Yazied Chothia, Laura K. Cobb, David J. Cohen +7 more

Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes

Diabetes Obesity and Metabolism(2020)10.1111/dom.14226

N/A

0DataRank · unranked

78 citations

Clare Arnott, Vlado Perkovic, Gemma A. Figtree, Dick de Zeeuw, Greg Fulcher +8 more

Bruce Neal

Indexed papers

Top data-sharing exemplar

Papers